Missouri Mental Health Advocate Not Optimistic About Medicaid Managed Care
The discussion about managed care comes as lawmakers continue to ignore pleas to expand Medicaid to 191,000 uninsured residents in Missouri. A White House report released earlier this month made a case for expansion but was largely ignored by expansion opponents.
Missouri’s next budget assumes an expansion of Medicaid managed care, but not everyone believes it will make things better for beneficiaries.
According to
“Your Medicaid providers haven’t received an increase in reimbursement in 25 years,” he said. “There is no money left for managed care to earn a living on. When you talk about managing care, there’s nothing to manage.”
Under the plan, an estimated 200,000 Medicaid beneficiaries are scheduled to move into managed care; the blind, elderly, and disabled will be exempt. Other speakers told the legislative panel that low reimbursement rates keep providers from taking Medicaid clients, and even critics of Medicaid have decried waits of 3 months or more to see certain specialists. But others say there are plenty of providers in Missouri’s system.
Missouri is an anomaly in the Medicaid landscape. It is 1 of only 3 states led by a Democrat that has not expanded Medicaid, as permitted by the Affordable Care Act. The question of whether to expand remains a volatile issue, with Republican candidate for governor
Those gaps, in fact, are the result of the loss of federal funds to cover the cost of uncompensated care; those funds have declined around the country on a schedule that assumed states would expand Medicaid to those earning between 100% and 138% of the federal poverty line.
In Missouri and elsewhere, business and hospital leaders have pushed for expansion but run into opposition from legislators opposed to anything that evokes support for the ACA. Broader use of managed care, which was already afoot, has been seen as a way to control costs, both in expansion and non-expansion states.
Earlier this month, Missouri lawmakers largely ignored a report from the
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025